CardiologyVideo course2026
30th Annual Heart Failure Update on Therapy 2026 — 30 talks from the field’s leading names
The 30th Annual Heart Failure 2026 symposium (An Update on Therapy), organised by Complete Conference Management and held on 13–14 March 2026 at the Millennium Biltmore Hotel in Los Angeles, is recorded here as 30 subtitled videos — about 10 hours 17 minutes. Clyde Yancy looks back on 30 years of innovation, Gregg Fonarow on maximising GDMT, and 20 more experts cover shock, myocarditis, amyloid, gene therapy, devices, congestion and hyperkalemia.
- 30sessions
- 22faculty
- 10 h 17 minof video
- Mar 2026recorded
What you’ll be able to do
- Get more from GDMT in HFrEF, including vericiguat, finerenone and digitalis
- Keep patients on RAAS inhibitors by managing hyperkalemia
- Decongest the hospitalised patient safely and efficiently
- Choose between LVAD and transplant and classify cardiogenic shock
- Apply the ESC 2025 myocarditis guideline and recognise checkpoint-inhibitor myocarditis
- Use myosin inhibitors, TTR drugs and gene therapy where they fit
Inside the course
Drug therapy that moves outcomes
GDMT optimisation, HFpEF across the EF spectrum, vericiguat after worsening, finerenone in CKD, DIG and DIGIT-HF on digitoxin and digoxin, hyperkalemia, obesity, a 240-year history of diuretics, and inpatient decongestion.
30th Annual Heart Failure 2026 advanced therapies
AI and remote monitoring, autonomic modulation, device innovation, LVAD versus transplant, cardiogenic shock classification, PCI in ischemic cardiomyopathy and new pulmonary hypertension therapies.
Cardiomyopathies, genetics and special cases
TTR amyloid drug selection, myosin inhibitors in HCM, genetic testing, gene and cell therapy, methamphetamine and peripartum cardiomyopathy, an HIV cardiogenic shock case panel, myocarditis, biomarkers and omics, and AF with heart failure.
Built for
- Cardiologists and HF specialistsA yearly benchmark update from long-standing leaders in the field.
- Internists and primary carePractical GDMT and decongestion strategies.
- Pharmacists and nursesClear guidance on the newest drugs and their monitoring.
Faculty & syllabus
Sessions and presenters 30 sessions
- Nir Uriel — Heart Failure: Artificial Intelligence and Remote Monitoring (21:42)
- Marvin Konstam — Heart Failure: Autonomic Modulation Today and Future Directions (20:59)
- Nir Uriel — LVAD vs Heart Transplant: Navigating Treatment Selection in Advanced Heart Failure (18:25)
- Mazen Hanna — Transthyretin Amyloidosis: Individualizing Drug Therapy Selection for Clinical Practice (18:07)
- Joshua Hare — Genetic Testing in Cardiovascular Disorders (16:38)
- Barry Greenberg — Gene Therapy for Patients with Cardiomyopathy (22:31)
- Joshua Hare — Cell and Gene Therapy for Cardiovascular Disorders (20:28)
- Uri Elkayam — Methamphetamine-Associated Cardiomyopathy: Early Recognition, Cessation, and Long-Term Management (13:36)
- Anilkumar Mehra, Uri Elkayam, Barry Greenberg, Leslie T. Cooper — HIV With Severe LV Dysfunction Presenting as Cardiogenic Shock (28:14)
- Anil K. Bhandari — Atrial Fibrillation and Heart Failure: Rhythm Control, GDMT, and Risk Factor Management (25:06)
- Clyde Yancy — Heart Failure Management: 30 Years of Innovation and Evolving Standards (34:12)
- Uri Elkayam — Peripartum Cardiomyopathy Management With Bromocriptine: Pathophysiologic Rationale and Available Evidence (13:43)
- Leslie T. Cooper — Myocarditis: Updates From the ESC 2025 Guidelines (21:27)
- Thomas Heywood — Pulmonary Hypertension: New Therapies and Their Clinical Use (21:15)
- William Abraham — Heart Failure: Innovations in Device Therapy (20:52)
- Jessica Wang — Hypertrophic Cardiomyopathy: Clinical Experience with Myosin Inhibitors in Obstructive and Nonobstructive Disease (19:23)
- Norman Lepor — Obesity in Patients With Heart Failure: Contemporary Management Strategies (24:18)
- Gregg Fonarow — GDMT for Chronic HFrEF: How to Maximize the Benefits? (23:15)
- Kirkwood F. Adams — Biomarkers and Omics in Heart Failure: Aids to Diagnosis and Therapy Monitoring (21:43)
- William Abraham — Treating Congestion in Acute Decompensated Heart Failure: Current Management and Future Directions (20:38)
- Eric Yang — Cardio-Oncology: Recognizing and Managing Immune Checkpoint Inhibitor Myocarditis (21:10)
- Marvin Konstam — Diuretic Therapy: How Has Management Evolved Over 240 Years? (13:18)
- Uri Elkayam — Hospitalized Patients With Decompensated Heart Failure: Optimizing Inpatient Diuresis and Decongestion (14:31)
- Ileana Pina — Hyperkalemia Management to Optimize RAASi and Maintain GDMT in Cardiorenal Disease (23:33)
- Tien Ng — Heart Failure Management With Digitoxin and Digoxin: What Do DIG and DIGIT-HF Tell Us? (18:43)
- Akshay S. Desai — Heart Failure and CKD: Integrating Finerenone Into Clinical Management (18:30)
- Barry Greenberg — HFrEF: When and How to Use Vericiguat in Patients With Worsening Heart Failure (16:30)
- Akshay S. Desai — HFpEF: Optimizing Guideline-Directed Medical Therapy Across the EF Spectrum (19:14)
- Rola Khedraki — Cardiogenic Shock: Hemodynamic Classification and Management Strategies (23:03)
- Christina Economides — Ischemic Cardiomyopathy: Does Percutaneous Coronary Intervention Improve Outcomes? (22:35)
Before you buy
Does it include slides?
No — the 2026 recording is video with subtitles only.
Is there an earlier edition?
Yes, the 29th Annual Heart Failure 2025 is available separately with 19 sessions.
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Video with subtitles (no PDFs) |
|---|---|
| Contents | 30 sessions · about 10 h 17 min |
| Recorded | 13–14 March 2026, Los Angeles |
| Organiser | Complete Conference Management |
| Department | Cardiology |
| Delivery | Instant download · lifetime re-download |
Related products
Anesthesiology
